Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina Habeck

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Drug Discovery Today|February 5, 2003
Mistletoe compound enters clinical trialsMartina Habeck
Drug Discovery Today|January 28, 2003
Benzodiazepine library yields lupus targetMartina Habeck
Drug Discovery Today|January 28, 2003
Boost for retinoic acid cancer therapyMartina Habeck
Drug Discovery Today|July 12, 2002
Starving cancer cellsMartina Habeck
Drug Discovery Today|January 30, 2002
New stroke therapies -- hope for the futureMartina Habeck
The Lancet. Oncology|March 22, 2002
FDA licences imatinib mesylate for CMLMartina Habeck
The Lancet. Infectious Diseases|March 5, 2003
Germany's smallpox jab plan meets with resistanceMartina Habeck
Drug Discovery Today|February 13, 2003
Jewels among the junkMartina Habeck
Nature Biotechnology|March 3, 2004
Germany reattempts to spark innovationMartina Habeck
The Lancet. Oncology|December 20, 2003
Australia approves thalidomideMartina Habeck
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Drug Discovery Today|February 5, 2003
Mistletoe compound enters clinical trialsMartina Habeck
Drug Discovery Today|January 28, 2003
Benzodiazepine library yields lupus targetMartina Habeck
Drug Discovery Today|January 28, 2003
Boost for retinoic acid cancer therapyMartina Habeck
Drug Discovery Today|July 12, 2002
Starving cancer cellsMartina Habeck
Drug Discovery Today|January 30, 2002
New stroke therapies -- hope for the futureMartina Habeck
The Lancet. Oncology|March 22, 2002
FDA licences imatinib mesylate for CMLMartina Habeck
The Lancet. Infectious Diseases|March 5, 2003
Germany's smallpox jab plan meets with resistanceMartina Habeck
Drug Discovery Today|February 13, 2003
Jewels among the junkMartina Habeck
Nature Biotechnology|March 3, 2004
Germany reattempts to spark innovationMartina Habeck
The Lancet. Oncology|December 20, 2003
Australia approves thalidomideMartina Habeck
Pageof 5